Skip to main content
Clinical Trials/JPRN-UMIN000002218
JPRN-UMIN000002218
Completed
Phase 2

A randomized trial to assess the effects of hydrogen-ride dissolution water for the patients with mild cognitive impairment (MCI). - An interventional trial for MCI using hydrogen-ride water.

Department of Neuropsychiatry, Institute of Clinical Medicine University of Tsukuba0 sites120 target enrollmentJuly 17, 2009

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
mild cognitive impairment
Sponsor
Department of Neuropsychiatry, Institute of Clinical Medicine University of Tsukuba
Enrollment
120
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 17, 2009
End Date
January 1, 2012
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Neuropsychiatry, Institute of Clinical Medicine University of Tsukuba

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Meeting DSM\-IV TR criteria for dementing illnesses. 2\) Having serious or unstable illnesses. 3\) Having a history within past 5 years of serious infectious disease affecting the brain and/or malignant diseases. 4\) Having a history of alcohol or drug abuse or dependence (on DSM\-IV TR) within the past 5 years. 5\) Receiving any types of anti\-Alzheimer drugs. 6\) Recent (within 4 weeks) initiation of medications that affect the central nervous system.

Outcomes

Primary Outcomes

Not specified

Similar Trials